Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 130 | 250 | 410 | 680 | 860 |
| Receivables | 10 | 40 | 30 | 20 | 120 |
| Other current assets | 50 | 40 | 110 | 40 | 130 |
| TOTAL | $190 | $330 | $550 | $740 | $1,110 |
| Non-Current Assets | |||||
| Investments And Advances | 170 | 150 | 130 | 90 | 0 |
| TOTAL | $170 | $150 | $130 | $90 | $N/A |
| Total Assets | $390 | $510 | $710 | $870 | $1,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 150 | 150 | 190 | 220 | 160 |
| Other current liabilities | 720 | 580 | 510 | 400 | 920 |
| TOTAL | $880 | $730 | $700 | $630 | $1,080 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $880 | $730 | $700 | $630 | $1,080 |
| Shareholders' Equity | |||||
| Common Shares | 1,440 | 1,440 | 1,440 | 1,440 | 1,440 |
| Retained earnings | -141,720 | -141,450 | -141,220 | -140,990 | -139,380 |
| Other shareholders' equity | 10 | 10 | 7 | 10 | -1,690 |
| TOTAL | $-490 | $-220 | $7 | $240 | $50 |
| Total Liabilities And Equity | $390 | $510 | $707 | $870 | $1,130 |